Development Division, FUJIREBIO INC., Tokyo, Japan.
Development Division, Advanced Life Science Institute, Inc., Tokyo, Japan.
Clin Biochem. 2023 Aug;118:110598. doi: 10.1016/j.clinbiochem.2023.110598. Epub 2023 Jun 16.
Human thyroglobulin (Tg) is widely used as a tumor marker for recurrence and metastasis of differentiated thyroid cancer (DTC). Currently, serum Tg values are measured using second-generation sandwich immunoassays (2nd-IMA). However, interference by endogenous autoantibodies to thyroglobulin (TgAbs) can lead to false-negative results or falsely low Tg values. Here, we describe a new Tg assay using the immunoassay for total antigen including complex via pretreatment (iTACT) method to prevent TgAb interference and compare it with 2nd-IMA.
Tg values were evaluated by three assays: iTACT Tg, Elecsys Tg-II, which is a 2nd-IMA, and LC-MS/MS (Liquid chromatography tandem-mass spectrometry). The ratio of Tg values between each assay was then compared to the Tg value by LC-MS/MS and TgAb titer. Tg immunoreactivity was analyzed by size-exclusion chromatography.
Correlation between iTACT Tg and LC-MS/MS using TgAb-positive specimens was good: Passing-Bablok regression with iTACT Tg = 1.084 × LC-MS/MS + 0.831. Correlation between 2nd-IMA and LC-MS/MS showed a relatively lower slope: 2nd-IMA = 0.747 × LC-MS/MS - 0.518. Thus, Tg values determined by iTACT Tg are equivalent to those of LC-MS/MS regardless of TgAb titer, whereas 2nd-IMA gave lower Tg values due to TgAb interference. Tg-TgAb complexes of various molecular weights were verified by size-exclusion chromatography. Tg values measured by 2nd-IMA fluctuated depending on the molecular weight of the Tg-TgAb complexes, whereas iTACT Tg accurately quantified Tg values regardless of the size of the Tg-TgAb complexes.
Tg values in TgAb-positive specimens were accurately determined by iTACT Tg. TgAb-positive specimens contain Tg-TgAb complexes of various molecular weights that interfere with Tg value determination by 2nd-IMA, whereas iTACT Tg is unaffected by the presence of Tg-TgAb complexes.
人甲状腺球蛋白(Tg)被广泛用作分化型甲状腺癌(DTC)复发和转移的肿瘤标志物。目前,血清 Tg 值采用第二代夹心免疫分析法(2 代-IMA)进行测量。然而,内源性抗甲状腺球蛋白自身抗体(TgAbs)的干扰可能导致假阴性结果或 Tg 值假性降低。在这里,我们描述了一种使用通过预处理(iTACT)方法检测总抗原的免疫分析来预防 TgAb 干扰的新 Tg 检测方法,并将其与 2 代-IMA 进行比较。
通过三种检测方法评估 Tg 值:iTACT Tg、Elecsys Tg-II(第二代 IMA)和 LC-MS/MS(液相色谱串联质谱)。然后将每种检测方法的 Tg 值比值与 LC-MS/MS 和 TgAb 滴度的 Tg 值进行比较。通过分子筛色谱分析 Tg 免疫反应性。
iTACT Tg 与 TgAb 阳性标本的 LC-MS/MS 之间相关性良好:Passing-Bablok 回归 iTACT Tg=1.084×LC-MS/MS+0.831。2 代-IMA 与 LC-MS/MS 之间的相关性显示出较低的斜率:2 代-IMA=0.747×LC-MS/MS-0.518。因此,无论 TgAb 滴度如何,iTACT Tg 测定的 Tg 值与 LC-MS/MS 相当,而 2 代-IMA 由于 TgAb 干扰导致 Tg 值较低。通过分子筛色谱验证了各种分子量的 Tg-TgAb 复合物。2 代-IMA 测定的 Tg 值随 Tg-TgAb 复合物的分子量而波动,而 iTACT Tg 则不受 Tg-TgAb 复合物大小的影响,准确地定量了 Tg 值。
iTACT Tg 可准确测定 TgAb 阳性标本中的 Tg 值。TgAb 阳性标本中含有各种分子量的 Tg-TgAb 复合物,这些复合物会干扰 2 代-IMA 测定 Tg 值,而 iTACT Tg 不受 Tg-TgAb 复合物的影响。